Loading patent…
AssigneesBoard of Trustees of the University of Arkansas, The United States of America as represented by the Department of Veterans Affairs
InventorsSudhir V. Shah, Alexei G. Basnakian, Yousri M. Barri
Estimating the term…
The present invention provides a method of determining whether an individual is at risk for atherosclerosis, comprising the step of measuring the level of cLDL and/or autoantibody to cLDL in a sample obtained from this individual. The invention further discloses a method of reducing carbamylation in an individual with a monomeric amino acid or other enzymatic or non-enzymatic inhibitors of carbamylation. The instant invention also provides a method to decrease the level of cLDL by direct elimination of cLDL from the blood or plasma of an individual. The invention also provides a method of treating or preventing atherosclerosis in an individual by inhibiting aggregation and/or deposition of cLDL in the individual.
A method of assessing treatment for atherosclerosis, comprising:
A method of treating an individual by reducing carbamylation of LDL in said individual, comprising:
Dependencies are inferred from the claim text.